AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
Key Factors That Define Strong ASX Stocks
April 04, 2025 06:45 PM AEDT| By Team Kalkine MediaHighlights,Competitive advantages help companies maintain dominance and growth in their industries.,Steady earnings indicate financial strength and operational efficiency.,A solid balance sheet provides flexibility for expansion and resilience.,A com...
Is CSL the Most Defensive Healthcare Stock on the ASX?
April 04, 2025 06:39 PM AEDT| By Team Kalkine MediaHighlights:,CSL operates in the,Healthcare Stocks,sector, producing essential medicines and vaccines.,The company's performance remains stable due to the consistent demand for healthcare services.,Many analysts view CSL as a defensive option within t...
Navigating Trade Tariffs: Impacts Across Key ASX Sectors
April 04, 2025 05:30 PM AEDT| By Team Kalkine MediaHighlights:,Mesoblast (ASX:MSB) maintains tariff exemption amid complex export procedures through Singapore.,Cettire (ASX:CTT) adjusts pricing structures as European luxury imports face new U.S. tariff constraints.,Whitehawk (ASX:WHK) aligns with a U...
Orthocell Secures FDA Clearance for Remplir and Enters US Nerve Repair Market
April 04, 2025 04:39 PM AEDT| By Team Kalkine MediaHighlights:,Orthocell receives FDA approval for Remplir, enabling entry into the US nerve repair market,Remplir will be manufactured in Perth using proprietary technology with no reliance on external royalties,Company prepared for US launch with inve...
Why Is Ansell Limited's Market Standing a Key Focus?
April 04, 2025 01:38 PM AEDT| By Team Kalkine MediaHighlights,Ansell Limited,(ASX:ANN),operates in the protective equipment sector, offering safety solutions across industries.,The company's valuation metrics indicate a divergence from its current trading position.,Various industry and financial fact...
What Does Dimerix Limited’s New Securities Quotation on ASX Mean?
April 04, 2025 01:35 PM AEDT| By Team Kalkine MediaHighlights,Dimerix Limited has issued 5,352 new fully paid ordinary securities on the Australian Securities Exchange (ASX).,The company operates in the biotechnology sector, focusing on therapies for chronic conditions.,This development aligns with i...
Why Is Mesoblast's Market Positioning Drawing Attention?
April 04, 2025 01:31 PM AEDT| By Team Kalkine MediaHighlights,Mesoblast,(ASX:MSB),remains a key entity in stem cell-based therapeutics despite recent stock fluctuations.,The company maintains that its flagship product is not subject to U.S. tariffs due to its manufacturing strategy.,Market sentiment...
How Are Trade Barriers Shaping Operations at Ansell (ASX:ANN)?
April 04, 2025 12:00 AM AEDT| By Team Kalkine MediaHighlights,Ansell manufactures key products across Asia, now impacted by U.S. tariff policies,The company has adjusted pricing strategies for the U.S. market to offset added costs.,Supply chain constraints underline ongoing challenges in balancing ma...
Is PolyNovo Limited (ASX:PNV) Delivering Value Through Innovation in Healthcare?
April 04, 2025 12:00 AM AEDT| By Team Kalkine MediaHighlights,PolyNovo operates in the biomedical field, focused on regenerative medical devices.,Recent attention has highlighted engagement across public and institutional participants.,Governance and strategic alignment are shaped by varied market in...
Genetic Signatures Limited: A Look at Insider Transactions and Ownership
April 03, 2025 05:37 PM AEDT| By Team Kalkine MediaHighlights:,Recent insider purchases reflect confidence in the company’s direction.,Insider ownership accounts for a portion of the company’s total shareholding.,No recent sales have been reported in the latest quarter.,Genetic Signatures Limited (AS...
Race Oncology Advances RC220 Phase 1 Solid Tumour Trial in Australia
April 03, 2025 04:34 PM AEDT| By Team Kalkine MediaHighlights:,Race Oncology Ltd has commenced patient enrolment for the RC220 Phase 1 clinical trial at the Southside Cancer Care Centre in New South Wales.,The study will assess safety, tolerability, and biomarker responses in patients receiving RC220...
Market Movements on the ASX: Key Sector Developments and Company Highlights
April 03, 2025 02:30 PM AEDT| By Team Kalkine MediaHighlights:,Information Technology, Energy, and Real Estate sectors drive shifts on the ASX.,Orthocell (ASX:OCC) awaits US FDA 510(k) clearance for its medical innovation.,Ramelius Resources (ASX:RMS) and Enova Mining (ASX:ENV) report operational mil...
Imugene Advances Phase 1 onCARlytics Trial with IV Dose Escalation for Solid Tumours
April 03, 2025 12:00 AM AEDT| By Team Kalkine MediaHighlights,Imugene Ltd (ASX:IMU) has progressed past the initial intravenous dose level in the Phase 1 onCARlytics trial following Cohort Review Committee clearance.,The OASIS study continues evaluating onCARlytics in combination with blinatumomab to...
Is Mesoblast (ASX:MSB) Still on Track After Therapeutic Breakthroughs?
April 03, 2025 12:00 AM AEDT| By Team Kalkine MediaHighlights,Mesoblast has advanced its clinical pipeline with new therapy approvals.,Recent share price weakness follows global market fluctuations.,Sector performance and global sentiment may be impacting valuation.,Mesoblast Limited operates within...
Cochlear Limited (ASX:COH) Responds to US Tariff Uncertainty Amid Exemption Clause
April 03, 2025 12:00 AM AEDT| By Team Kalkine MediaHighlight:,Cochlear products currently benefit from a US import duty exemption,Awaiting further clarification from US Customs on 10% tariff changes,North America remains a critical export destination for Cochlear,Cochlear Limited (ASX:COH), a global...
CSL Evaluates Broader Implications of U.S. Tariff Measures on Global Operations
April 03, 2025 12:00 AM AEDT| By Team Kalkine MediaHighlights:,CSL Limited (ASX:CSL) confirms pharmaceutical products currently exempt from new U.S. import tariffs.,Broader implications of country-specific levies on European manufacturing operations under review.,Continued monitoring of evolving U.S....
Fisher & Paykel Healthcare (ASX:FPH) Navigates Tariff Fears Amid Shifting US Trade Policy
April 03, 2025 12:00 AM AEDT| By Team Kalkine MediaHighlights,Tariff Impact in FY25 Expected to Be Minimal:,Fisher & Paykel Healthcare does not foresee a material effect on its FY25 net profit after tax from recent U.S. tariff changes.,Increased Exposure in FY26:,Cost pressures and foreign exchange r...
How Might Policy Changes Affect CSL Ltd (ASX:CSL) Global Medical Supply?
April 03, 2025 12:00 AM AEDT| By Team Kalkine MediaHighlights,CSL Ltd share performance responds to U.S. tariff discussions.,European manufacturing may face strategic shifts if policies tighten.,U.S. plasma operations remain critical to CSL's healthcare focus.,The pharmaceutical and biotechnology ind...
Investors Remain Pessimistic About Neuren Pharmaceuticals Limited's (NEU) Outlook
April 02, 2025 07:31 PM AEDT| By Team Kalkine MediaHighlights:,Neuren Pharmaceuticals reports a price-to-earnings ratio below the broader market.,The company's earnings have shown a decline, influencing its valuation.,Market expectations indicate continued financial challenges in the coming years.,Ne...
Insider Transactions at AdAlta Limited Amid Stock Movement
April 02, 2025 07:31 PM AEDT| By Team Kalkine MediaHighlights:,Insiders at AdAlta Limited experienced a stock price decrease, affecting past transactions.,Stuart Morris made the largest recorded insider acquisition at a specific price per share.,Insider ownership remains significant, aligning closely...
Advertise your brand on Kalkine Media